

Cover Story
By Matthew Bin Han Ong
NCI-designated cancer centers will soon be able to extend their Cancer Center Support Grant award period from five years to seven years, depending on merit at peer review, sustained exceptional progress, stability, and longevity of the cancer center.
In Brief


Clinical Roundup
Trending Stories
- Class action complaint alleging GRAIL insider fraud resubmitted after dismissal
- How George Tidmarsh crossed the FDA-industry Rubicon
- Cancer centers adapt to life without site visits as NIH changes CCSG review
- Revolution Medicines’ pancreatic cancer drug received a new priority voucher from FDA
- How GLP-1RA drugs are reshaping patient physiology and the future of oncology
- CDER Director Tidmarsh quits amid inspector general probe of his “personal conduct”
Cancer advocates express concern about comments that signal trouble for accelerated approval















